Patent: 7,722,865
✉ Email this page to a colleague
Summary for Patent: 7,722,865
| Title: | Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof |
| Abstract: | This invention provides compositions of active highly phosphorylated lysosomal sulfatase enzymes, their pharmaceutical compositions, methods of producing and purifying such lysosomal sulfatase enzymes and compositions and their use in the diagnosis, prophylaxis, or treatment of diseases and conditions, including particularly lysosomal storage diseases that are caused by, or associated with, a deficiency in the lysosomal sulfatase enzyme. |
| Inventor(s): | Michel Claude Vellard, Vish Koppaka |
| Assignee: | Biomarin Pharmaceutical Inc |
| Application Number: | US12/629,029 |
| Patent Claims: | see list of patent claims |
Details for Patent 7,722,865
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc. | NAGLAZYME | galsulfase | Injection | 125117 | May 31, 2005 | 7,722,865 | 2029-12-01 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 7,722,865
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Africa | 201004674 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2009091994 | ⤷ Start Trial |
| United States of America | 9873867 | ⤷ Start Trial |
| United States of America | 9200264 | ⤷ Start Trial |
| United States of America | 8420368 | ⤷ Start Trial |
| United States of America | 8128925 | ⤷ Start Trial |
| United States of America | 2021189357 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
